September 4-7 2018
Boston, MA


Twitter logo for website footers 2

CAR-TCR Industry Survey 2018

The infographic provides some great insights into solid tumor approaches, commercial impact and limitations of manufacturing strategies.

Interviews with: Juno Therapeutics, Cellectis, ZIOPHARM, Kite Pharma

On a mission to find out what the future holds for the CAR-TCR space, we sat down with: Hans Bishop, CEO, Juno Therapeutics; André Choulika, CEO, Cellectis; Laurence Cooper, CEO, ZIOPHARM and David Chang, CMO, Kite, Pharma to talk shop.

September

CAR-TCR Industry Survey 2017

The industry results provide some great insights into manufacturing challenges, key design factors for the next generation of CAR-TCR therapies and pricing models for these therapies.

CAR-TCR Industry Survey 2017

Major Highlights of the CAR-TCR Summit, Boston 2016

Vita Golubovskaya, Robert Berahovich, Shirley Xu, Hizkia Harto and Lijun Wu present their highlights from the CAR-TCR Summit 2016

CAR-TCR Highlights

CAR-TCR 2016 Post Event Report

Post event report provides great insight into exciting discussions and sessions presented at the CAR-TCR Summit

CAR-TCR 2016 Post Event Report

CAR-TCR Industry Survey 2016

The industry results provide some great insights into manufacturing challenges, key design factors for the next generation of CAR-TCR therapies and pricing models for these therapies.

CAR-TCR 2016 Survey Results

CAR-T Summit 2015 Highlights

Take a look at the highlights from the CAR-TCR Summit 2015

CAR-TCR 2015 Post Event Highlights

CAR-T Industry Survey 2015

The industry results provide some great insights into manufacturing challenges, key design factors for the next generation of CAR-TCR therapies and pricing models for these therapies.

CAR-TCR 2015 Survey Results